SCHEMBL24813246

SCHEMBL24813246

c1ccc(-n2c3ccccc3c3ccc(-c4ccc5c6ccccc6n(-c6ccc(-c7ccc(-c8ccc9c(c8)sc8ccccc89)cc7)cc6)c5c4)cc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR3 P46089 1/20 0.39
HDAC4 P56524 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
GAA P10253 1/20 0.35
IL1R1 P14778 1/20 0.34
LIMK1 P53667 1/20 0.34
HTT P42858 1/20 0.33
KHK P50053 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24811998 1.00 ATM (0.50) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL24174204 0.97 L3MBTL1 (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL23601939 0.97 L3MBTL1 (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL24812161 0.97 L3MBTL1 (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL12088877 0.96 ATM (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL17285095 0.96 ATM (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL16804104 0.96 ATM (0.46) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL17228245 0.96 ATM (0.49) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL18505107 0.95 ATM (0.47) ATML3MBTL1KDM4EALDH1A1MAPT
SCHEMBL24174197 0.95 L3MBTL1 (0.44) ATML3MBTL1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 US disclosed
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 ATM 3436/4885L3MBTL1 1876/4885KDM4E 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.